Webber Philip M
Frank B Dehn & Co, Patent and Trade Mark Attorneys, St Bride's House, 10 Salisbury Square, London, EC4Y 8JD, UK.
IDrugs. 2007 Jul;10(7):459-62.
Patent laws covering NCEs are well established in most developed countries. For such entities to be patentable, they must be novel, inventive and have some practical use. Furthermore, the patent applications must describe how to make the entities, and provide data to support the patent claims. The same criteria are being applied by Patent Offices to the patenting of the new generation of biotech products: genes, proteins, microorganisms, transgenic plants and transgenic animals. This feature review focuses on the patenting of these novel products.
在大多数发达国家，涵盖新化学实体（NCEs）的专利法已很完善。对于此类可获专利的实体，它们必须具备新颖性、创造性且有实际用途。此外，专利申请必须描述如何制造这些实体，并提供数据以支持专利权利要求。专利局对新一代生物技术产品（基因、蛋白质、微生物、转基因植物和转基因动物）的专利授予也采用相同标准。本专题综述聚焦于这些新型产品的专利情况。
